Drug Information

Drug General Information
Drug ID
D08DGW
Former ID
DNCL003364
Drug Name
CXL
Drug Type
Small molecular drug
Indication Methicillin-resistant staphylococcus aureus infection [ICD10:B95.62] Phase 2 [550289]
Company
AstraZeneca
Structure
Download
2D MOL

3D MOL
Formula
C6H12O
Canonical SMILES
C1CCC(CC1)O
InChI
1S/C6H12O/c7-6-4-2-1-3-5-6/h6-7H,1-5H2
InChIKey
HPXRVTGHNJAIIH-UHFFFAOYSA-N
PubChem Compound ID
7966
PubChem Substance ID
4111, 474020, 824792, 4761790, 7886824, 8143892, 8155509, 10503680, 11108074, 14709712, 15140941, 17389602, 24846712, 24854538, 26706632, 29226725, 29375357, 37351750, 37360597, 37399790, 38324432, 46504858, 48415086, 48417205, 48420293, 48423185, 48425000, 49816808, 49854677, 53837752, 57244159, 57324639, 57392442, 68530696, 79831465, 85085040, 85165220, 88826713, 92252594, 92309348, 93165743, 102852060, 103202967, 104316509, 104667461, 117617277, 124759891, 124890266, 125231083, 125293029
Target and Pathway
Target(s) Beta-lactamase Target Info Modulator [551120]
References
Ref 550289Clinical pipeline report, company report or official report of AstraZeneca.
Ref 551120Beta-Lactam Antibiotics Renaissance. Antibiotics. 2014, 3(2), 193-215.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.